Clinical trials
General Population (no Specific Condition or Disease) clinical trials
Below are recruiting general population (no specific condition or disease) clinical trials, each written for real people, not researchers. We’re tracking 10,803 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07140367Recruiting
Artery treatment for inflammatory knee arthritis
This trial tests if a minimally invasive procedure that blocks small arteries can reduce pain and swelling in arthritic knees. It's for people with moderate knee osteoarthritis who still have pain after trying other treatments and are already considering knee replacement surgery.
Bologna, BolognaAges 40 years+ - NCT07140731Recruiting
Symani Restore study for moyamoya disease surgery
This study tests if the Symani surgical system helps surgeons perform a delicate brain blood-vessel bypass in people with moyamoya disease. It may offer a precise, minimally invasive option for those needing neurosurgery.
Buffalo, New YorkAges 18 years+ - NCT07141043Recruiting
Bone health study after kidney transplant
This study looks at bone and mineral disorders in people on dialysis, after a kidney transplant, or with bone thinning. It aims to understand how these conditions affect bone health.
IașiAges 20–70 - NCT07141862Recruiting
Fertility preservation in children with solid tumors
This trial studies whether there are any cancer cells in the tissue taken to preserve fertility in children with neuroblastoma or Ewing sarcoma. The goal is to make sure the preserved tissue is safe to use later.
Clermont-Ferrand, AuvergneAges 2–45 - NCT07142252RecruitingPhase 2
New drug for recently diagnosed type 1 diabetes
This trial tests a new medicine (rezpegaldesleukin) to see if it can help preserve the body's ability to make some insulin in people recently diagnosed with type 1 diabetes. It's for children and adults diagnosed within the past 100 days.
Aurora, ColoradoAges 8–45 - NCT07143266Recruiting
Sleep study for people with pituitary and hypothalamus conditions
This study looks at sleep problems in people whose hypothalamus or pituitary gland does not work normally. It compares their sleep with healthy volunteers to better understand how these conditions affect rest.
BarcelonaAges 18–70 - NCT07143617Recruiting
Safety study of STR-P004 for lupus and inflammatory muscle disease
This trial tests the safety of a new treatment called STR-P004 for people with systemic lupus erythematosus (SLE) or certain inflammatory muscle diseases that have not improved with standard therapies. It may be an option if your condition is hard to control.
BeijingAges 18 years+ - NCT07143734RecruitingPhase 2
Brain stimulation for early Alzheimer's disease
This study tests a new, noninvasive brain stimulation method called Transcranial Pulse Stimulation (TPS) for people in the early stages of Alzheimer's disease. The goal is to see if it can help improve symptoms.
Hong KongAges 60–90 - NCT07143968RecruitingPhase 2
Resmetirom for people with MASLD and HIV
This study tests if resmetirom can help people who have both HIV and a liver condition called MASLD (fat buildup in the liver not caused by alcohol). You may qualify if your liver has a certain amount of fat and stiffness, and your HIV is well controlled with stable medication.
Birmingham, AlabamaAges 18 years+ - NCT07144085RecruitingPhase 1
Testing a new PET scan tracer for cancer diagnosis
This trial tests a new type of PET/CT scan that uses a special tracer (called ⁶⁸Ga-FXX489) to help find and diagnose cancers. It is for people who are strongly suspected to have cancer and want to see if this new imaging method can help their doctors learn more about their disease.
Shenyang, LiaoningAges 18–80 - NCT07145190Recruiting
Starting Sublingual Apomorphine for Parkinson's OFF Episodes
This study looks at how patients start and adjust a new medicine (sublingual apomorphine, or SL-APO) for Parkinson's disease OFF episodes. OFF episodes are times when Parkinson's symptoms come back between medicine doses. If you are about to start SL-APO for the first time, this trial may be a good fit.
BerlinAges 18 years+ - NCT07145697RecruitingPhase 4
EEG study of anesthesia and consciousness in epilepsy
This trial tests how anesthesia affects brain activity in people with drug-resistant epilepsy who need brain electrode monitoring. It may help us understand consciousness and improve anesthesia safety.
Guangzhou, GuangdongAges 3–65 - NCT07145736RecruitingPhase 4
Comparing two drugs to control river blindness and other neglected diseases
This trial tests if moxidectin works better than ivermectin for controlling river blindness and other neglected tropical diseases. Both drugs are given as a single dose during mass treatment campaigns in villages.
Andulo, Bíe ProvinceAges 5 years+ - NCT07145918RecruitingPhase 2
Study of an oral schizophrenia drug for adults
This trial tests an experimental oral drug (emraclidine) to see if it helps symptoms of schizophrenia and how it moves through the body. It looks at two groups of participants: those with stable symptoms and those having an acute flare-up.
Little Rock, ArkansasAges 18–65 - NCT07146412Recruiting
Lifestyle changes to lower dementia risk for older adults
This research study tests whether a program of healthy eating, exercise, and other lifestyle changes can lower your risk for dementia. It is designed for people aged 65–75 with a family history of dementia who want to take steps to keep their brain healthy.
Huntsville, AlabamaAges 65–75 - NCT07146776Recruiting
Injectable PRF and bone graft for gum disease bone defects
This trial tests a treatment for deep gum disease pockets using a combination of your own blood components (injectable platelet-rich fibrin) and a bone graft material. It aims to help regenerate bone lost to periodontitis.
Istanbul, ÜsküdarAges 18–65 - NCT07146854Recruiting
EndoForce Connector Study for Dialysis Graft Access
This study is testing a new connector system (EndoForce) used during dialysis graft placement in people with kidney failure. Researchers want to make sure it works safely and effectively in real-world use.
Orangeburg, South CarolinaAges 18 years+ - NCT07147465Recruiting
Using gene sequencing to improve cancer care
This study looks at how well a special type of gene testing (called sequencing) works for people with cancer. It aims to learn if this test helps doctors choose better treatments.
LyonAges Any age - NCT07148050RecruitingPhase 1
CAR T-cell therapy for children with solid tumors
This trial tests a new kind of immunotherapy for children and teens with solid tumors that have not responded to standard treatments. The therapy uses specially engineered T cells (CAR T cells) that target a protein called GPC3 found on many tumor cells, and it includes extra signals (IL-15 and IL-21) to help the T cells work better.
Seattle, WashingtonAges 1–26 - NCT07148154Recruiting
Non-invasive test for endometrial cancer screening
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
L'Hospitalet de Llobregat, BarcelonaAges 40 years+ - NCT07148180RecruitingPhase 1/Phase 2
Targeting leftover leukemia cells with a combination therapy
This trial tests a new drug combo (tagraxofusp, azacitidine, and venetoclax) for people with acute myeloid leukemia (AML) who have very small amounts of cancer cells still present after initial treatment. The goal is to see if it can clear these leftover cells and prevent the cancer from coming back.
Boston, MassachusettsAges 18 years+ - NCT07148492Recruiting
Stitch to prevent reflux after gastric bypass
This trial tests adding an antireflux stitch to a type of gastric bypass surgery to see if it helps reduce acid reflux. It may help patients who are already scheduled for this surgery.
Peshawar, KhyberpukhtunkhwaAges Any age - NCT07150624RecruitingPhase 4
Polyene phosphatidylcholine for liver injury after surgery
This trial tests whether a medicine called polyene phosphatidylcholine can help protect the liver from damage after surgery for liver cancer. It is for people who are having a specific type of keyhole surgery to remove part of the liver.
Hefei, AnhuiAges 18–70 - NCT07151222Recruiting
Red blood cells and heart disease in type 2 diabetes
This study looks at the role of red blood cells in heart disease risk for people with type 2 diabetes. It may help us understand how to better prevent heart problems.
Stockholm, SwsdenAges 25–80
Hear when a new General Population (no Specific Condition or Disease) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for general population (no specific condition or disease)?
- Yes. Clin2 currently lists 10,803 recruiting general population (no specific condition or disease) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a general population (no specific condition or disease) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a general population (no specific condition or disease) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.